Загрузка...
SAT-465 Somatostatin Receptor Ligand as Initial Therapy in a Patient with Pituitary Microadenoma and Acromegaly: Temporary Remission and Recurrence
BACKGROUND: Transsphenoidal surgery is recommended as initial therapy for microadenomas causing acromegaly. Primary medical therapy with somatostatin analogues has shown to cause a reduction in the size of microadenomas and secretion of growth hormone. Normalization of IGF-1 levels with somatostatin...
Сохранить в:
| Опубликовано в: : | J Endocr Soc |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Endocrine Society
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552506/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-465 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|